Surgery Partners (SGRY) Akcija Kursas

Surgery Partners Kursas

NASDAQ·UŽDARTAS
23,24
​
Rinka uždaryta

Pajamos augo 23,2 % per metus per pastaruosius 14 metus iki 3,31 mlrd. USD. Pelnas akcijai mažėjo 43,4 % per metus per pastaruosius 4 metus. Surgery Partners grynoji marža dabar yra −2,4 %, iš esmės stabili nuo −3,2 % prieš kelerius metus. Analitikų tikslinės kainos mediana yra 18,50 USD, t. y. žemiau dabartinę kainą 20,4 %. Iš 18 analitikų 14 rekomenduoja pirkti — bendras konsensusas yra Pirkti.

Surgery Partners akcijos kaina

Gaukite šiuos duomenis per Eulerpool API

100 000 užklausų/mėn. nemokamai · be kortelės

Surgery Partners akcija ir akcijų analizė

Surgery Partners Inc yra JAV bendrovė, specializuojasi specializuotose chirurgijos paslaugose Jungtinėse Valstijose. Ji įkurta 1997 m., o būstinė įsikūrusi Nacvilėje, Tenesyje. Bendrovė koncentruojasi į ambulatorines chirurgines procedūras, teikdama įvairias medicinos paslaugas, įskaitant akių chirurgiją, endoskopiją, ENT (ausų, nosies ir gerklės) chirurgiją, ginekologiją, ortopedinę chirurgiją, plastikinę chirurgiją ir urologiją. „Surgery Partners“ valdo daugiau nei 180 chirurgijos centrų ir praktikų 32 valstijose. Paslaugų portfelį ji išplėtė 2017 m. įsigijusi „Symbion Healthcare“, kuri teikia anestezijos paslaugas, skausmo valdymą, diagnostikos ir laboratorines paslaugas. Bendrovė taip pat akcentuoja aukštos kokybės aptarnavimą ir sudaro partnerystes su ligoninėmis, kad plėstų savo chirurgines paslaugas.

Dažnai užduodami klausimai apie Surgery Partners akciją

Surgery Partners Inc is primarily active in the healthcare industry. With a focus on providing surgical services, the company operates a network of outpatient surgical facilities, physician practices, and anesthesia services. By offering a comprehensive range of surgical solutions, Surgery Partners Inc aims to improve patient outcomes and enhance healthcare delivery. With its expertise in specialties such as orthopedics, gastroenterology, and ophthalmology, the company plays a crucial role in meeting the diverse healthcare needs of patients across different regions. Overall, Surgery Partners Inc's activities support the advancement and accessibility of quality healthcare services.

The business model of Surgery Partners Inc centers around providing a comprehensive range of surgical services through its network of ambulatory surgery centers, surgical hospitals, and contract services. With a focus on delivering high-quality, cost-effective care, Surgery Partners Inc aims to meet the needs of patients, physicians, and healthcare facilities. By offering a diverse range of surgical specialties, including orthopedics, gastroenterology, and ophthalmology, Surgery Partners Inc strives to improve patient outcomes and satisfaction. Through its strategic partnerships and operational expertise, the company continues to expand its footprint and strengthen its position within the healthcare industry.

The main competitors of Surgery Partners Inc in the market include Tenet Healthcare Corporation, HCA Healthcare, and UnitedHealth Group.

Surgery Partners Inc is a leading healthcare services company with an extensive history in the industry. Established in 2004, Surgery Partners has since grown to become a prominent player in providing surgical services across the United States. With a focus on delivering high-quality care in a cost-effective manner, the company operates a network of surgical facilities and ancillary services centers. Through strategic partnerships, Surgery Partners offers a range of surgical procedures in various specialties, ensuring access to a wide range of patients in need. With their commitment to exceptional patient care, Surgery Partners Inc has established itself as a trusted name in the healthcare sector.

Surgery Partners Inc has achieved several significant milestones in its history. One notable accomplishment includes the strategic acquisition of National Surgical Healthcare in 2017, which expanded the company's reach and capabilities in the outpatient surgical market. Additionally, Surgery Partners Inc achieved recognition as a leader in ambulatory surgery, providing high-quality healthcare services across multiple states. The company has also demonstrated consistent growth and financial performance, further establishing its position in the healthcare industry. Surgery Partners Inc continues to prioritize patient care and innovation, driving its success and reinforcing its reputation as an esteemed company in the stock market.

Surgery Partners Inc is primarily present in the United States.

Surgery Partners Inc values the highest standards of patient care, innovation, and excellence in healthcare services. With a patient-centric approach, the company strives to provide the most advanced surgical solutions and personalized care. The corporate philosophy revolves around compassionate healthcare delivery, continuous improvement, and ethical practices. Surgery Partners Inc is committed to fostering strong relationships with physicians, patients, and partners, while maintaining a focus on operational efficiency and financial strength. The company's dedication to quality outcomes, cutting-edge technology, and commitment to patient satisfaction embodies its core values and corporate philosophy.

Analitikai šiuo metu nustato vidutinę Surgery Partners akcijos tikslinę kainą 18,75 USD (mediana: 18,50 USD), t. y. −19,3 % palyginti su paskutine kaina. Konsensusas pagrįstas 18 analitikų reitingais.

18 analitikai šiuo metu vertina Surgery Partners akciją: 14 rekomenduoja pirkti, 4 laikyti ir 0 parduoti. 2026 m. analitikai tikisi, kad Surgery Partners gaus 3,35 mlrd. USD pajamų ir 0,40 USD pelno akcijai.

Pagal dabartinį kursą Surgery Partners akcija kainuoja 20,85 EUR (23,24 USD).

Surgery Partners akcija (SGRY) kotiruojama 4 biržose, įskaitant: NASDAQ (SGRY), Frankfurt (1SP.F), München (1SP.MU), Düsseldorf (1SP.DU).

Surgery Partners Inc. is a leading healthcare company that focuses on outpatient surgical centers and services for the healthcare industry. The company offers a variety of surgical and diagnostic services delivered on an outpatient basis. Surgery Partners Inc. operates over 180 facilities in 31 states in the USA and provides a wide range of surgical services. The business model of Surgery Partners Inc. is based on the goal of providing its patients with top-quality surgical services and continuous medical care at the highest level. The company has an extensive network of outpatient surgical centers and offers its patients a wide range of surgical and diagnostic services, including general surgery, orthopedics, ophthalmology, neurology, gastroenterology, gynecology, and many others. Surgery Partners Inc. also offers specialized procedures and services such as endoscopic examinations, imaging services, pain therapy, and rehabilitation. The company also operates an extensive diagnostic platform that includes advanced imaging technology and diagnostic procedures such as endoscopy and biopsy. The company also has a focus on the development and utilization of cutting-edge technology in surgery and diagnostics to ensure that patients receive excellent medical care. Surgery Partners Inc. also maintains extensive partnerships with healthcare providers and hospitals to enable better coordinated care. The company collaborates with numerous facilities to meet the needs of patients and provide them with a seamless healthcare experience. These partnerships allow Surgery Partners Inc. to expand its network of facilities and improve its services. Surgery Partners Inc. is also actively involved in research and development, working to develop new procedures and technologies to improve surgical services. The company has a strong team of researchers and physicians who continuously seek new opportunities to enhance surgery and diagnostics, thereby ensuring better healthcare. Overall, the business model of Surgery Partners Inc. is focused on providing top-quality surgical and diagnostic services on an outpatient basis. The company operates an extensive network of surgical facilities and offers a wide range of surgical and diagnostic services to meet the needs of its patients. Through healthcare partnerships and the use of cutting-edge technologies, Surgery Partners Inc. strives to provide better healthcare for its patients.

tikėtina pelnas Surgery Partners yra 3,35 mlrd. USD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.

tikėtina grynasis pelnas Surgery Partners yra 51,10 mln. USD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.

Kainų ir nuomos santykis (KGV) Surgery Partners šiuo metu yra 57,85. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Surgery Partners akcijos vertę.

Kainų ir pardavimų santykis (KUV) Surgery Partners šiuo metu yra 0,88. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Surgery Partners akcijos įvertinimo metrika.

Eulerpool kokybės balas Surgery Partners yra 3/10.

Surgery Partners ISIN yra US86881A1007. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.

Surgery Partners WKN yra A14YWP. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.

Surgery Partners prekybos žymė yra SGRY. Ši biržos žymė naudojama Surgery Partners akcijoms prekiauti biržoje.

Tikroji vertėTerminal
21,38 USD
Per/Nepakankamai vertintaTerminal
Teisingai vertinta
Sektorius
Industrija
Sveikatos priežiūros teikėjai ir paslaugos
Akcijų skaičius
Darbuotojai
Pajamos vienam darbuotojui
206 793,75 USD
Pajamų augimas Ø5 metai
EBIT augimas Ø5 metai
Grynojo pelno augimas Ø5 metai
Valiuta
USD
Pirminis viešas pasiūlymas
2015-10-01
ISIN
US86881A1007
CUSIP
86881A100
SEDOL
BYTC1B2
Rinkos kapitalizacija
52 savaičių diapazonas
AAQS
3 / 10
PEG
−4,50
P/E santykis
K/P santykise 2026
57,36
K/P santykise 2027
53,88
K/P santykise 2028
38,85
K/P santykise 2029
41,50
P/S
K/A santykise
0,88
EV/EBIT
16,52
P/B santykis
1,71
ROE (nuosavo kapitalo grąža)
ROA (turto grąža)
ROCE (grąža iš panaudoto kapitalo)
ROIC (grąža iš investuoto kapitalo)
−1,43 %
Paskutinį kartą atnaujinta 2026-10-29 14:54

Surgery Partners Biržos simbolis

DIUSELDORFAS · 1SP.DUFRANKFURTAS · 1SP.FMIUNCHENAS · 1SP.MUNASDAQ · SGRY

Surgery Partners FIGI

SGRY:US · BBG009T0TKV8SGRY:UA · BBG009T0TLN5SGRY:UC · BBG009T0TLP3SGRY:UN · BBG009T0TLR1SGRY:UP · BBG009T0TLS0SGRY:UB · BBG009T0TLV6SGRY:UM · BBG009T0TLX4SGRY:UX · BBG009T0TLY3SGRY:UD · BBG009T0TM35SGRY:UW · BBG009T0TM53SGRY:UF · BBG009T0TM62SGRY:VY · BBG009T0TM71